2022 AACC News
Video from AACC: Siemens Healthineers’ NAFLD test
Leo O'Connor, Editor in Chief
July 28, 2022
Siemens Healthineers CMO Charles Cooper spoke to us about the firm’s Enhanced Liver Fibrosis blood test and how it can be used to assess the risk of nonalcoholic fatty liver disease (NAFLD) progression and liver-related events.
Click on the video below for the interview.
Siemens Healthineers at AACC
Siemens Healthineers CMO Charles Cooper.
If you like this content, please share it with a colleague!
Siemens Healthineers unveils in vitro diagnostics systems at AACC 2022
At AACC 2022 on Tuesday, Siemens Healthineers unveiled the Atellica CI 1900 Analyzer, a clinical chemistry and immunoassay testing system and lower volume...
Siemens Healthineers Q2 sales driven by diagnostics, Varian
Strong contributions from COVID-19 antigen tests -- coupled with sales from its Varian radiation therapy division -- helped drive revenues for Siemens...
Siemens begins shipping COVID tests to households in the U.S.
Siemens Healthineers has begun distributing millions of its CliniTest Rapid COVID-19 Antigen Self-Tests following its selection on January 24 as...
Siemens launches ELF test in the U.S. for NASH assessment
Siemens Healthineers has launched its Enhanced Liver Fibrosis (ELF) blood test in the U.S., designed to assess disease progression in people with nonalcoholic...
Copyright © 2022 LabPulse.com
Last Updated 7/29/2022 1:08:48 PM